Damineni Surekha1, Kagitha Sailaja1, Dunna Nageswara Rao1, Tirunalai Padma1, Digumarthi Raghunadharao2, Satti Vishnupriya1
1 Department of Genetics, Osmania University, Hyderabad, Andhra Pradesh, India
2 Department of Medical Oncology, Nizams Institute of Medical Sciences, Hyderabad, Andhra Pradesh, India
DOI: 10.4103/0976-9668.136150
| ABSTRACT |
Background: The CYP19 gene is located on chromosome 15 and it plays an important role in aromatization, which results in production of estrogen from androgens. The mutation in this gene can result in either increased or decreased aromatase activity. Materials and Methods: A case-control study was designed to compare 250 breast cancer cases with 250 age-matched healthy controls. The frequency distribution of CYP19 polymorphism was assessed by polymerase chain reaction confronting two pair primers (PCR-CTPP). Results: CYP19 polymorphism at codon 39 Trp/Arg (W39R) results in three genotypes TT, TC, and CC, but in the present study CC genotype was not found in breast cancer cases as well as in controls. The TT genotype was significantly elevated in disease (90.8%) as compared to controls (68.5%). The frequency of TC was found to be increased in premenopausal women with breast cancer (12.2%) and the frequency of TT genotype was increased in patients who were postmenopausal (94.1%). The increased frequency of heterozygotes was found in cases with familial incidences of cancer (10.8%), estrogen and progesterone receptor positive status, node positive status (9.8%), and occupied in agriculture (14.8%). Higher frequencies of both TT and TC genotype were increased in patients with high body mass index (BMI). The frequency of TT genotype was found to be increased in advanced stage of the disease. Conclusion: Hence, we conclude that W39 with increased aromatase activity confers greater risk to develop breast cancer especially in postmenopausal women and might also contribute to advanced stage.
Keywords: Aromatization, breast cancer, CYP19, polymorphisms, receptor status
